DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Registry of Patients Treated With Plerixafor (MozobilĀ®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Information source: Sanofi
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Bone Marrow / Autologous Transplants

Intervention: Plerixafor (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Genzyme, a Sanofi Company

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Genzyme, a Sanofi Company

Summary

The aim of this registry is to provide information, in day-to-day practice, on Plerixafor prescription modalities in France, over a 13-month period in order to address the health authorities' request.

Clinical Details

Official title: Investigator Centers Will Be All French Hematology Centers Performing Autologous Transplantation and Prescribing Mozobil in Hematopoietic Stem Cell Mobilization Willing to Participate In This Study

Study design: Time Perspective: Prospective

Primary outcome:

The characteristics of the patients who received treatment

Dosage of treatment

Number of CD34+ cells collected following treatment

Number of patients with the existence of one or more predictive factors of poor mobilisation

Duration of treatment

Associated treatments

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients treated with Plerixafor for autologous transplantation between November 2011

and November 2012

- Patients who have been informed and who have given their written consent for the

access to their medical file Exclusion Criteria:

- Patients already included in a Plerixafor ongoing clinical trial.

Locations and Contacts

Marseille, France
Additional Information

Starting date: December 2011
Last updated: March 19, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017